AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 114 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,154,066 | +57427.1% | 1,121,327 | 0.0% | 0.38% | -34.0% |
| Q2 2023 | $12,436 | -27.7% | 1,121,327 | 0.0% | 0.58% | -31.8% |
| Q1 2023 | $17,212 | -99.9% | 1,121,327 | 0.0% | 0.85% | -35.5% |
| Q4 2022 | $24,882,246 | +35.9% | 1,121,327 | 0.0% | 1.31% | +27.4% |
| Q3 2022 | $18,311,000 | +12.4% | 1,121,327 | 0.0% | 1.03% | -0.2% |
| Q2 2022 | $16,293,000 | -21.3% | 1,121,327 | 0.0% | 1.03% | -3.0% |
| Q1 2022 | $20,711,000 | -22.3% | 1,121,327 | 0.0% | 1.06% | +2.8% |
| Q4 2021 | $26,654,000 | -3.5% | 1,121,327 | 0.0% | 1.04% | +7.4% |
| Q3 2021 | $27,618,000 | -0.3% | 1,121,327 | 0.0% | 0.96% | -1.4% |
| Q2 2021 | $27,708,000 | +13.3% | 1,121,327 | 0.0% | 0.98% | +18.0% |
| Q1 2021 | $24,456,000 | -14.5% | 1,121,327 | 0.0% | 0.83% | -9.9% |
| Q4 2020 | $28,616,000 | -9.3% | 1,121,327 | 0.0% | 0.92% | -15.7% |
| Q3 2020 | $31,565,000 | -0.4% | 1,121,327 | 0.0% | 1.09% | -21.7% |
| Q2 2020 | $31,689,000 | – | 1,121,327 | – | 1.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
| COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
| Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
| 5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
| RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
| RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
| COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
| Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
| Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
| Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |